"Paromomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oligosaccharide antibiotic produced by various STREPTOMYCES.
Descriptor ID |
D010303
|
MeSH Number(s) |
D09.408.051.623.635
|
Concept/Terms |
Paromomycin- Paromomycin
- Estomycin
- Hydroxymycin
- Aminosidine
- Paramomycin
- Paromomycin I
- Catenulin
- Neomycin E
|
Below are MeSH descriptors whose meaning is more general than "Paromomycin".
Below are MeSH descriptors whose meaning is more specific than "Paromomycin".
This graph shows the total number of publications written about "Paromomycin" by people in this website by year, and whether "Paromomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Paromomycin" by people in Profiles.
-
Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment. J Mol Graph Model. 2020 11; 100:107697.
-
Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19. Int J Infect Dis. 2020 Sep; 98:166-175.
-
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infect Dis. 2017 07 07; 17(1):478.